Maytas Pharmaceutical Company has recently developed a new, fast acting cold/flu medicine, which includes two variants: one is for use at night and another for daytime use. The firm's target market consisted of 1000 consumers belonging to one of four segments, A, B, C, and D. The segment sizes and each segment's willingness to pay for a box of cold/flu medicine appear in the table below.

Willingness To Pay Day Medicine Night Medicine Segment A (25%) $1.00 $9.00 Segment B (25%) $4.00 $8.00 Segment C (25%) $8.00 $4.50 Segment D (25%) $9.00 $1.00